HEALTH POLICY BRIEF — Friday, May 29

Executive Briefing

- CMS/CMMI transplant model final rule is on public inspection for June 1. CMS is finalizing Performance Year 2 updates to the mandatory Increasing Organ Transplant Access model, effective 30 days after Federal Register publication. Policy relevance: this is not a digital health item, but it is a fresh CMMI mandatory model update affecting participating kidney transplant hospitals, performance scoring, beneficiary notices, and downside/upside risk mechanics. Physician policy angle: specialty practices and transplant programs may care about attribution, patient notice, quality scoring, and payment risk. Source: https://www.federalregister.gov/public-inspection/2026-10890/medicare-program-alternative-payment-model-updates-and-the-increasing-organ-transplant-access-model

- NIST reissued and refocused its AI consortium notice. NIST is retitling the AI Safety Institute Consortium as the NIST Artificial Intelligence Consortium, revising its research scope, and reopening letters of interest on an ongoing basis, with the first review beginning within 60 days of today’s notice. Policy relevance: this is a cross-sector AI standards/governance venue, not health-specific, but it may shape federal AI measurement and evaluation frameworks that later influence health AI assurance. Physician policy angle: worth monitoring for physician-led AI governance, clinical validation, privacy, bias, safety, workflow, and accountability use cases. Source: https://www.federalregister.gov/documents/2026/05/29/2026-10779/nist-artificial-intelligence-consortium

- FDA extended comments on its AI-enabled early-phase clinical trials RFI to June 29. The RFI seeks input on a proposed pilot program to assess AI-enabled technologies for improving efficiency, speed, and quality of decision-making in early-phase clinical trials. Policy relevance: this is a concrete HHS/FDA comment opportunity in health AI. Physician policy angle: relevant to clinical evidence standards, trial operations, patient safety, clinician oversight, and how AI-enabled trial tools should be evaluated before broader medical use. Source: https://www.federalregister.gov/documents/2026/05/28/2026-10602/ai-enabled-optimization-of-early-phase-clinical-trials-pilot-program-request-for-information

Federal Health Policy Watch

- CMS/CMMI IOTA final rule: Finalizes selected updates for Performance Year 2, beginning July 1, 2026, and future years of the six-year mandatory model. Notable provisions include excluding VA and military treatment facilities, raising the low-volume eligibility threshold from 11 to 15 kidney transplants in each baseline year, modifying the composite graft survival quality methodology, removing voluntary health equity plan provisions, and changing beneficiary notification mechanics. Policy relevance: specialty model implementation and CMMI mandatory-model precedent. Physician policy angle: monitor for how CMS handles specialty-care accountability models, risk adjustment, participant burden, and beneficiary communications.

- CMS PRA notice: CMS opened a 30-day OMB review comment period, due June 29, on the Social Security Office Report of State Buy-in Problems collection. Policy relevance is low for this publication’s coverage focus; it is primarily a Medicare/Medicaid eligibility administration collection rather than a physician-practice burden item. Source: https://www.federalregister.gov/documents/2026/05/29/2026-10777/agency-information-collection-activities-submission-for-omb-review-comment-request

Congress / Hearings / Oversight

- No meaningful fresh congressional hearing, markup, bill movement, or oversight signal surfaced this morning for health IT, AI, privacy, cybersecurity, interoperability, prior authorization, physician payment, or coding.

Digital Health / AI / Privacy / Cyber / Interoperability

- NIST AI Consortium notice: Monitor as an upstream federal AI standards and measurement forum. The health policy hook is whether health care stakeholders participate early enough to push clinical safety, workflow fit, privacy, bias, and accountability into general-purpose AI evaluation frameworks.

- FDA AI clinical trials RFI extension: Comment window now runs through June 29. This is the most concrete fresh health AI action item today. Potential comment angles include clinician oversight, validation expectations, transparency of AI-driven trial decisions, data quality, generalizability, patient safety, and how FDA should distinguish operational trial optimization from clinical decision support.

Prior Authorization / Payer Policy / Administrative Simplification

- No new official prior authorization or administrative simplification action found this morning. The X scan surfaced renewed discussion of CMS’s electronic prior authorization early-adopter initiative, but the underlying CMS announcement is from May 13, not a new development today, so I’m not treating it as fresh.

Standards / Coding / Data Infrastructure

- No fresh HL7, Da Vinci, X12, NCPDP, TEFCA, USCDI, CPT, or certification item requiring action this morning. The NIST AI consortium notice is adjacent to standards strategy, but it is not health-data-specific.

Signal Scan

- X/social scan status: completed with findings. Credible signals mostly pointed back to already-known CMS electronic prior authorization and Medicaid payment items, plus general implementation commentary on AI, interoperability, and data infrastructure. Strategic read: no fresh social signal changes the advocacy picture this morning; the only useful reminder is that implementation stakeholders are still emphasizing real-world workflow, payer coverage-rule structure, and EHR integration as the hard part of FHIR-enabled prior authorization.